These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 4572837)

  • 1. Serum enterotoxin-neutralizing antibody in human shigellosis.
    Keusch GT; Jacewicz M
    Nat New Biol; 1973 Jan; 241(105):31-2. PubMed ID: 4572837
    [No Abstract]   [Full Text] [Related]  

  • 2. Serologic response of patients with shiga dysentery.
    Cáceres A; Mata LJ
    J Infect Dis; 1974 Apr; 129(4):439-43. PubMed ID: 4593873
    [No Abstract]   [Full Text] [Related]  

  • 3. [Passive hemagglutination tests with Shigella flexneri and Shigella sonnei antigens in the diagnosis of dysentery].
    Prokopowicz D
    Wiad Lek; 1972 Jul; 25(11):977-80. PubMed ID: 4557140
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum IgG antibody responses to Shigella invasion plasmid-coded antigens detected by immunoblot.
    Li A; Zhao CR; Ekwall E; Lindberg AA
    Scand J Infect Dis; 1994; 26(4):435-45. PubMed ID: 7984976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population.
    Cohen D; Green MS; Block C; Rouach T; Ofek I
    J Infect Dis; 1988 May; 157(5):1068-71. PubMed ID: 3283258
    [No Abstract]   [Full Text] [Related]  

  • 6. Future needs and directions for Shigella vaccines.
    Wkly Epidemiol Rec; 2006 Feb; 81(6):51-8. PubMed ID: 16673461
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies of crossed immunity between different serotypes of dysentery bacilli and the keratoconjunctivitis-positive, lactoso-negative strain 47552 deprived of Shigella agglutinogen].
    Ciufeco C
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):389-94. PubMed ID: 4925072
    [No Abstract]   [Full Text] [Related]  

  • 8. [Obtaining dysentery and salmonellosis diagnostica for the coagglutination reaction in lyophilized form and the elaboration of a rapid system].
    Belaia IuA; Belaia OF
    Lab Delo; 1982; (8):486-8. PubMed ID: 6182376
    [No Abstract]   [Full Text] [Related]  

  • 9. The Shigella human challenge model.
    Porter CK; Thura N; Ranallo RT; Riddle MS
    Epidemiol Infect; 2013 Feb; 141(2):223-32. PubMed ID: 22906296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New directions in the study of immunity in dysentery].
    Pokrovskiĭ VI; Godovannyĭ BA; Iushchuk ND
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):6-12. PubMed ID: 6346759
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum antibody responses against shigella lipopolysaccharides and invasion plasmid-coded antigens in shigella infected Swedish patients.
    Li A; Rong ZC; Ekwall E; Forsum U; Lindberg AA
    Scand J Infect Dis; 1993; 25(5):569-77. PubMed ID: 8284641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of indirect hemagglutination in the seroepidemiology of Shigella infections.
    Patton CM; Gangarosa EJ; Weissman JB; Merson MH; Morris GK
    J Clin Microbiol; 1976 Feb; 3(2):143-8. PubMed ID: 767361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shigellosis: the current status of vaccine development.
    Kweon MN
    Curr Opin Infect Dis; 2008 Jun; 21(3):313-8. PubMed ID: 18448978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neutralizing action of human blood preparations on Shigella enterotoxins and choleragen].
    Kamzolkina NB; Borisova IV; Mitskevich ED
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jun; (6):64-8. PubMed ID: 6205524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of differentiation of antibodies to Shigella organisms according to the immunoglobulin class in the serological diagnostics of dysentery and in study of its epidemiology.
    Hasenson LB; Gennadeva TY; Lullu AV
    J Hyg Epidemiol Microbiol Immunol; 1971; 15(3):298-307. PubMed ID: 4938457
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of antisera to detect virulent Yersinia enterocolitica, Shigella and Escherichia coli enteroinvasive.
    Giannini MJ; de Medeiros BM; Bauab TM; Carlos IZ; de Toledo MR; Trabulsi LR; Falcão DP
    Contrib Microbiol Immunol; 1991; 12():164-70. PubMed ID: 1935085
    [No Abstract]   [Full Text] [Related]  

  • 17. Shigellosis in Vietnam: seroepidemiologic studies with use of lipopolysaccharide antigens in enzyme immunoassays.
    Lindberg AA; Cam PD; Chan N; Phu LK; Trach DD; Lindberg G; Karlsson K; Kärnell A; Ekwall E
    Rev Infect Dis; 1991; 13 Suppl 4():S231-7. PubMed ID: 2047643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shigella lipopolysaccharide antibodies in pediatric populations.
    Passwell JH; Freier S; Shor R; Farzam N; Block C; Lison M; Shiff E; Ashkenazi S
    Pediatr Infect Dis J; 1995 Oct; 14(10):859-65. PubMed ID: 8584312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials of Shigella vaccines in Israel.
    Cohen D; Ashkenazi S; Green M; Gdalevich M; Yavzori M; Orr N; Robin G; Slepon R; Lerman Y; Block C; Ashkenazi I; Taylor D; Hale L; Sadoff J; Schneerson R; Robbins J; Wiener M; Shemer J
    Adv Exp Med Biol; 1996; 397():159-67. PubMed ID: 8718595
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunity in shigellosis. I. Response of man to attenuated strains of Shigella.
    DuPont HL; Hornick RB; Snyder MJ; Libonati JP; Formal SB; Gangarosa EJ
    J Infect Dis; 1972 Jan; 125(1):5-11. PubMed ID: 4550417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.